103828 Federal Register / Vol. 89, No. 244 / Thursday, December 19, 2024 / Notices 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in the BHC Act 

(12 U.S.C. 1842(c)). 

Comments received are subject to 

public disclosure. In general, comments 

received will be made available without 

change and will not be modified to 

remove personal or business 

information including confidential, 

contact, or other identifying 

information. Comments should not 

include any information such as 

confidential information that would not 

be appropriate for public disclosure. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than January 21, 2025. 

A. Federal Reserve Bank of Boston 

(Prabal Chakrabarti, Senior Vice 

President) 600 Atlantic Avenue, Boston, 

Massachusetts 02210–2204. Comments 

can also be sent electronically to 

BOS.SRC.Applications.Comments@

bos.frb.org: 

1. Winchester Bancorp, MHC, 

Winchester, Massachusetts; to become a 

bank holding company by acquiring at 

least 50.1 percent of the voting shares of 

Winchester Bancorp, Inc., a mid-tier 

holding company, through a mutual 

holding company reorganization and 

minority stock issuance, and thereby 

indirectly acquiring voting shares of 

Winchester Savings Bank, both of 

Winchester, Massachusetts. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Associate Secretary of the Board. 

[FR Doc. 2024–30299 Filed 12–18–24; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (Act) (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12 

CFR 225.41) to acquire shares of a bank 

or bank holding company. The factors 

that are considered in acting on the 

applications are set forth in paragraph 7 

of the Act (12 U.S.C. 1817(j)(7)). 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in paragraph 7 of 

the Act. 

Comments received are subject to 

public disclosure. In general, comments 

received will be made available without 

change and will not be modified to 

remove personal or business 

information including confidential, 

contact, or other identifying 

information. Comments should not 

include any information such as 

confidential information that would not 

be appropriate for public disclosure. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than January 3, 2025. 

A. Federal Reserve Bank of Richmond 

(Brent B. Hassell, Assistant Vice 

President) P.O. Box 27622, Richmond, 

Virginia 23261. Comments can also be 

sent electronically to 

Comments.applications@rich.frb.org: 

1. The Craig G. Phillips Revocable 

Trust, Craig G. Phillips, as trustee, both 

of Buckhannon, West Virginia; to 

acquire voting shares of Freedom 

Bancshares, Inc., and thereby indirectly 

acquire voting shares of Freedom Bank, 

Inc., both of Belington, West Virginia. 

Board of Governors of the Federal 

Reserve System. 

Michele Taylor Fennell, 

Associate Secretary of the Board. 

[FR Doc. 2024–30298 Filed 12–18–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Supplemental Evidence and Data 

Request on Impact of Healthcare 

Worker Safety and Wellness: A 

Systematic Review 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for supplemental 

evidence and data submission. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public. Scientific information is 

being solicited to inform our review on 

Impact of Healthcare Worker Safety and 

Wellness: A Systematic Review, which 

is currently being conducted by the 

AHRQ’s Evidence-based Practice 

Centers (EPC) Program. Access to 

published and unpublished pertinent 

scientific information will improve the 

quality of this review. 

DATES: Submission Deadline on or 

before January 21, 2025. 

ADDRESSES:

Email submissions: epc@

ahrq.hhs.gov. 

Print submissions: 

Mailing Address: Center for Evidence 

and Practice Improvement, Agency for 

Healthcare Research and Quality, 

ATTN: EPC SEADs Coordinator, 5600 

Fishers Lane, Mail Stop 06E53A, 

Rockville, MD 20857 

Shipping Address (FedEx, UPS, etc.): 

Center for Evidence and Practice 

Improvement, Agency for Healthcare 

Research and Quality, ATTN: EPC 

SEADs Coordinator, 5600 Fishers 

Lane, Mail Stop 06E77D, Rockville, 

MD 20857 

FOR FURTHER INFORMATION CONTACT: 

Kelly Carper, eelephone: 301–427–1656 

or email: epc@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Agency for Healthcare Research and 

Quality has commissioned the 

Evidence-based Practice Centers (EPC) 

Program to complete a review of the 

evidence for Impact of Healthcare 

Worker Safety and Wellness: A 

Systematic Review. AHRQ is conducting 

this review pursuant to section 902 of 

the Public Health Service Act, 42 U.S.C. 

299a. 

The EPC Program is dedicated to 

identifying as many studies as possible 

that are relevant to the questions for 

each of its reviews. In order to do so, we 

are supplementing the usual manual 

and electronic database searches of the 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 244 / Thursday, December 19, 2024 / Notices 103829 

literature by requesting information 

from the public (e.g., details of studies 

conducted). We are looking for studies 

that report on Impact of Healthcare 

Worker Safety and Wellness: A 

Systematic Review. The entire research 

protocol is available online at: https://

effectivehealthcare.ahrq.gov/products/ 

worker-safety-wellness/protocol. 

This is to notify the public that the 

EPC Program would find the following 

information on Impact of Healthcare 

Worker Safety and Wellness: A 

Systematic Review helpful: 

D A list of completed studies that 

your organization has sponsored for this 

topic. In the list, please indicate 

whether results are available on 

ClinicalTrials.gov along with the 

ClinicalTrials.gov trial number. 

D For completed studies that do not 

have results on ClinicalTrials.gov, a 

summary, including the following 

elements, if relevant: study number, 

study period, design, methodology, 

indication and diagnosis, proper use 

instructions, inclusion and exclusion 

criteria, primary and secondary 

outcomes, baseline characteristics, 

number of patients screened/eligible/ 

enrolled/lost to follow-up/withdrawn/ 

analyzed, effectiveness/efficacy, and 

safety results. 

D A list of ongoing studies that your 

organization has sponsored for this 

topic. In the list, please provide the 

ClinicalTrials.gov trial number or, if the 

trial is not registered, the protocol for 

the study including, if relevant, a study 

number, the study period, design, 

methodology, indication and diagnosis, 

proper use instructions, inclusion and 

exclusion criteria, and primary and 

secondary outcomes. 

D Description of whether the above 

studies constitute ALL Phase II and 

above clinical trials sponsored by your 

organization for this topic and an index 

outlining the relevant information in 

each submitted file. 

Your contribution is very beneficial to 

the Program. Materials submitted must 

be publicly available or able to be made 

public. Materials that are considered 

confidential; marketing materials; study 

types not included in the review; or 

information on topics not included in 

the review cannot be used by the EPC 

Program. This is a voluntary request for 

information, and all costs for complying 

with this request must be borne by the 

submitter. 

The draft of this review will be posted 

on AHRQ’s EPC Program website and 

available for public comment for a 

period of 4 weeks. If you would like to 

be notified when the draft is posted, 

please sign up for the email list at: 

https://effectivehealthcare.ahrq.gov/ 

email-updates. 

The review will answer the following 

questions. This information is provided 

as background. AHRQ is not requesting 

that the public provide answers to these 

questions. 

Contextual Question: What are the 

manifestations of impaired safety and 

wellbeing of HCWs, such as burnout, 

moral injury, emotional exhaustion, 

staff turnover, and physical injuries? 

Key Questions (KQ) 

KQ 1: What are the associations 

between healthcare delivery conditions 

and HCW burnout? 

KQ 2: What are the associations 

between HCW burnout and outcomes 

for patients, HCW families, healthcare 

delivery organizations, and society? 

KQ 3: What are the effectiveness and 

harms of system-level interventions 

targeting HCW burnout? 

PECOTS (POPULATIONS, EXPOSURES, COMPARATORS, OUTCOMES, TIMING AND SETTING) ELIGIBILITY CRITERIA FOR ALL

KEY QUESTIONS

Element Key Question 1 Key Question 2 Key Question 3 

Population ......... HCWs at all organizational levels (e.g., those who provide direct patient care, support personnel, managers, executives) Examples: 

• Physicians. 

• Nurses: registered nurses and advanced practice nurses. 

• Pharmacists. 

• Allied healthcare professionals (e.g., respiratory therapists, physical therapists, social workers, emergency medical technicians). 

• Support personnel (e.g., environmental services). 

• Managers. 

• Executives. 

Exposure ........... All healthcare delivery conditions associated 

with the included studies will be recorded as 

exposures, including 

• Societal conditions, including federal 

and state laws like nurse staffing laws, 

policies like pandemic restrictions and 

credentialing, and unemployment, 

healthcare utilization, and unionization 

rates. 

• Organizational factors such as payment 

model, level of care, precarious and unstable scheduling, safety culture. 

• Job and task-specific factors, such as 

occupational class, shift characteristics, 

working hours, occupational stressors, 

support, teamwork, and workplace hazards Individual factors, such as age and 

experience. 

HCW burnout, including instruments such as: 

• Maslach Burnout Inventory 

• Oldenburg Burnout Inventory 

• Copenhagen Burnout Inventory 

• Two-Item Maslach Burnout Inventory 

• Physician Worklife Study Single Item 

Question 

• ProQOL Burnout scale 

• Institute for Professional Worklife Mini Z 

Survey 

System-level programs: interventions that intend to reduce or prevent HCW burnout 

through the elimination or substitution of occupational hazards. 

Exclude: interventions that enable the occupational hazard to remain in place (engineering, administrative controls) or increase the 

individual capacity to cope with the hazard 

(PPE, resilience training). 

Comparator ....... Other healthcare delivery condition. Other levels of HCW burnout. • Other intervention. 

• No intervention. 


lotter on DSK11XQN23PROD with NOTICES1
103830 Federal Register / Vol. 89, No. 244 / Thursday, December 19, 2024 / Notices 

PECOTS (POPULATIONS, EXPOSURES, COMPARATORS, OUTCOMES, TIMING AND SETTING) ELIGIBILITY CRITERIA FOR ALL

KEY QUESTIONS—Continued 

Element Key Question 1 Key Question 2 Key Question 3 

Outcomes .......... HCW burnout, including instruments such as: 

• Maslach Burnout Inventory 

• Oldenburg Burnout Inventory 

• Copenhagen Burnout Inventory 

• Two-Item Maslach Burnout Inventory 

• Physician Worklife Study Single Item 

Question 

• Professional Quality of Life (ProQOL) 

Burnout scale 

• Institute for Professional Worklife Mini Z 

Survey 

• HCW family outcomes, such as: 

Æ Marital/relationship stress measured by 

a partner 

Æ Divorce/separation rates 

• Patient outcomes, such as: 

Æ Safety 

Æ Satisfaction 

Æ Adverse events 

Æ Mortality 

• Healthcare organization outcomes, such as: 

Æ Productivity (including presenteeism, 

absenteeism, work-related injuries and 

illnesses) 

Æ Staff turnover (including due to retirement, leaving the profession, mortality, 

or suicide) 

• Societal outcomes, such as: 

Æ Workforce shortages 

HCW burnout, including instruments such as: 

• Maslach Burnout Inventory. 

• Oldenburg Burnout Inventory. 

• Copenhagen Burnout Inventory. 

• Two-Item Maslach Burnout Inventory. 

• Physician Worklife Study Single Item 

Question. 

• ProQOL Burnout scale. 

• Institute for Professional Worklife Mini Z 

Survey. 

Mediating Factors.• Individual factors such as stress, satisfaction, wellbeing, engagement, sleep quality, suicidal ideation, depression, anxiety, meaningful work, 

mattering, moral distress or injury, workplace injury or illness. 

Modifying Factors.Æ Demographic characteristics: (e.g., age, sex, race, ethnicity). 

Æ Occupational title (e.g., physician, nurse, allied health professional, other). 

Æ Educational attainment (e.g., high school, some college, college degree, graduate degree). 

Æ Experience (e.g., number of years employed). 

Æ Income (e.g., household income, socioeconomic status). 

Æ Time (e.g., year of outcome ascertainment, or binned by pre-, concurrent and post-pandemic). 

Æ Shift characteristics: (e.g., timing, duration, knowledge of shift, mandatory overtime). 

Æ Job tasks (e.g., patient-facing vs. non-patient-facing, physical demands as high, moderate, low). 

Æ Geographic location (e.g., U.S. census region, urban vs. suburban vs. rural). 

Study Designs ... • Cross-sectional studies. 

• Cohort studies. 

• Randomized controlled trials. 

• Non-randomized controlled trials. 

• Observational cohort studies with a comparison group. 

• Pre-post studies (with adjustment for confounders). 

Timing ............... Published since 2014. 

Settings ............. All U.S. healthcare delivery settings where HCWs work (e.g., ambulatory, prehospital, emergency, various inpatient services, post-acute or skilled 

nursing/long-term care, including medical, surgical, and mental health care settings). 

Abbreviations: HCW = healthcare worker; PPE = personal protective equipment, ProQOL = Professional Quality of Life. 

Dated: December 12, 2024. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2024–30259 Filed 12–18–24; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to 5 U.S.C. 1009(d), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention, pursuant to Public Law 92– 

463. The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel; 

(SEP)—RFA–OH–25–002, Panel A, 

Occupational Safety and Health 

Education and Research Centers (ERC). 

Dates: February 24–25, 2025. 

Times: 11:00 a.m.–5:00 p.m., EST. 

Place: Video-Assisted Meeting. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Dan 

Hartley, Ed.D., Scientific Review 

Officer, Office of Extramural Programs, 

National Institute for Occupational 

Safety and Health, Centers for Disease 

Control and Prevention, 1095 

Willowdale Road, Morgantown, West 

Virginia 26505. Telephone: (304) 285– 

5812; Email: DHartley@cdc.gov. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–30238 Filed 12–18–24; 8:45 am] 

BILLING CODE 4163–18–P 


lotter on DSK11XQN23PROD with NOTICES1